Paper26445238
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
Noll JE and 7 others. J Hematol Oncol, 2015. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma. Papers, record 26445238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26445238
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Proliferation | Major topic |
| Gene Expression Profiling | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Multiple Myeloma | Major topic |
| Securin | Major topic |
| Animals | |
| Blotting, Western | |
| Cell Cycle | |
| Cell Line, Tumor | |
| Female | |
| Male | |
| Mice, Inbred C57BL | |
| Microscopy, Confocal | |
| Neoplasms, Experimental | |
| Oligonucleotide Array Sequence Analysis | |
| Plasma Cells | |
| Prognosis | |
| RNA Interference | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Survival Analysis | |
| Tumor Burden |
Source PubMed
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18753362 | Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update. | Endocr Relat Cancer | 2008 | https://conductscience.org/library/papers/18753362 | PubMed |
| 2 | 17204181 | [Expression of pituitary tumor-transforming gene in patients with multiple myeloma]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2006 | https://conductscience.org/library/papers/17204181 | PubMed |
| 3 | 22722715 | A gene expression signature for high-risk multiple myeloma. | Leukemia | 2012 | https://conductscience.org/library/papers/22722715 | PubMed |
| 4 | 10029599 | Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease. | Blood | 1999 | https://conductscience.org/library/papers/10029599 | PubMed |
| 5 | 12727994 | Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. | J Clin Endocrinol Metab | 2003 | https://conductscience.org/library/papers/12727994 | PubMed |
| 6 | 20884712 | Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma. | Haematologica | 2011 | https://conductscience.org/library/papers/20884712 | PubMed |
| 7 | 20128661 | Identification of a common gene expression signature associated with immature clonal mesenchymal cell populations derived from bone marrow and dental tissues. | Stem Cells Dev | 2010 | https://conductscience.org/library/papers/20128661 | PubMed |
| 8 | 21314937 | Identification of early molecular markers for breast cancer. | Mol Cancer | 2011 | https://conductscience.org/library/papers/21314937 | PubMed |
| 9 | 10656688 | Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. | Oncogene | 2000 | https://conductscience.org/library/papers/10656688 | PubMed |
| 10 | 9892021 | Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). | Mol Endocrinol | 1999 | https://conductscience.org/library/papers/9892021 | PubMed |
| 11 | 16809406 | The emerging role of pituitary tumor transforming gene in tumorigenesis. | Clin Med Res | 2006 | https://conductscience.org/library/papers/16809406 | PubMed |
| 12 | 16426442 | The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer. | J Carcinog | 2006 | https://conductscience.org/library/papers/16426442 | PubMed |
| 13 | 11920212 | The 5TMM series: a useful in vivo mouse model of human multiple myeloma. | Hematol J | 2000 | https://conductscience.org/library/papers/11920212 | PubMed |
| 14 | 11753617 | Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. | Leukemia | 2001 | https://conductscience.org/library/papers/11753617 | PubMed |
| 15 | 10580151 | Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG). | Gene | 1999 | https://conductscience.org/library/papers/10580151 | PubMed |
| 16 | 20587513 | Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. | Cancer Res | 2010 | https://conductscience.org/library/papers/20587513 | PubMed |
| 17 | 10682678 | p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10682678 | PubMed |
| 18 | 17065388 | Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. | J Endocrinol | 2006 | https://conductscience.org/library/papers/17065388 | PubMed |
| 19 | 18591550 | Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18591550 | PubMed |
| 20 | 19298592 | The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma. | Br J Haematol | 2009 | https://conductscience.org/library/papers/19298592 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959892 | A proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma. | Blood Neoplasia | 2026 | https://conductscience.org/library/papers/42959892 | PubMed |
| 41976385 | Intranuclear Peripheral Overexpression of Pituitary-Tumor-Transforming Gene 1: Immunohistochemical Biomarker of Lymph Node Involvement in Testicular Seminoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976385 | PubMed |
| 40263435 | Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma. | Leukemia | 2025 | https://conductscience.org/library/papers/40263435 | PubMed |
| 40072059 | The Role of RAC2 and PTTG1 in Cancer Biology. | Cells | 2025 | https://conductscience.org/library/papers/40072059 | PubMed |
| 39855192 | Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/39855192 | PubMed |
| 39678599 | Comprehensive analysis of the pituitary tumor-transforming gene (PTTG) family in lung adenocarcinoma: diagnostic, prognostic, and therapeutic implications. | Am J Transl Res | 2024 | https://conductscience.org/library/papers/39678599 | PubMed |
| 39511416 | Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma. | Cancer Gene Ther | 2025 | https://conductscience.org/library/papers/39511416 | PubMed |
| 39296974 | Roles of DEPDC1 in various types of cancer (Review). | Oncol Lett | 2024 | https://conductscience.org/library/papers/39296974 | PubMed |
| 37727504 | Smarca4 deficiency induces Pttg1 oncogene upregulation and hyperproliferation of tubular and interstitial cells during kidney development. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37727504 | PubMed |
| 37174118 | Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37174118 | PubMed |
| 36630696 | Integration of Single-Cell Transcriptomics With a High Throughput Functional Screening Assay to Resolve Cell Type, Growth Kinetics, and Stemness Heterogeneity Within the Comma-1D Cell Line. | Front Genet | 2022 | https://conductscience.org/library/papers/36630696 | PubMed |
| 36466549 | Identifying the Effect of COVID-19 Infection in Multiple Myeloma and Diffuse Large B-Cell Lymphoma Patients Using Bioinformatics and System Biology. | Comput Math Methods Med | 2022 | https://conductscience.org/library/papers/36466549 | PubMed |
| 36449634 | High-Throughput Cellular Heterogeneity Analysis in Cell Migration at the Single-Cell Level. | Small | 2023 | https://conductscience.org/library/papers/36449634 | PubMed |
| 35281830 | A Comprehensive Pan-Cancer Analysis for Pituitary Tumor-Transforming Gene 1. | Front Genet | 2022 | https://conductscience.org/library/papers/35281830 | PubMed |
| 35239126 | Bayesian penalized Buckley-James method for high dimensional bivariate censored regression models. | Lifetime Data Anal | 2022 | https://conductscience.org/library/papers/35239126 | PubMed |
| 33173433 | Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients. | Int J Med Sci | 2020 | https://conductscience.org/library/papers/33173433 | PubMed |
| 33061798 | Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma. | Int J Biol Sci | 2020 | https://conductscience.org/library/papers/33061798 | PubMed |
| 32354870 | Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression. | Haematologica | 2021 | https://conductscience.org/library/papers/32354870 | PubMed |
| 32014459 | Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma. | Cancer Lett | 2020 | https://conductscience.org/library/papers/32014459 | PubMed |
| 31385458 | PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc. | Cancer Med | 2019 | https://conductscience.org/library/papers/31385458 | PubMed |
Genes48
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26445238
GET https://conductscience.org/api/papers/v1/26445238/references?page=2